Nodal Disease in Breast Cancer Predicts in Breast Pathologic Complete Response

被引：0
|
作者：
Baldwin, X. [1 ]
Downs-Canner, S. [1 ]
Maduekwe, U. N. [1 ]
机构：
[1] Univ N Carolina, Gen Surg, Chapel Hill, NC 27515 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P67
引用
收藏
页码：S71 / S71
页数：1
相关论文
共 50 条
  • [1] In-breast pathologic complete response (pCR) following neoadjuvant chemotherapy predicts nodal pCR in early stage breast cancer
    Shamseddine, Achraf
    Flynn, Jessica
    Zhang, Zhigang
    Morrow, Monica
    Mueller, Boris
    Gillespie, Erin
    Khan, Atif
    McCormick, Beryl
    Cahlon, Oren
    Powell, Simon
    Barrio, Andrea
    Braunstein, Lior Z.
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [2] Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer
    Bufi, Enida
    Belli, Paolo
    Di Matteo, Marialuisa
    Giuliani, Michela
    Tumino, Mariavalentina
    Rinaldi, Pierluigi
    Nardone, Luigia
    Franceschini, Gianluca
    Mule, Antonino
    Bonomo, Lorenzo
    [J]. CLINICAL BREAST CANCER, 2016, 16 (06) : E193 - E201
  • [3] Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk
    Judy C. Boughey
    Tanya L. Hoskin
    Courtney N. Day
    Matthew P. Goetz
    [J]. Annals of Surgical Oncology, 2022, 29 : 6254 - 6264
  • [4] Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk
    Boughey, Judy C.
    Hoskin, Tanya L.
    Day, Courtney N.
    Goetz, Matthew P.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (10) : 6254 - 6264
  • [5] Distinct Prognosis of Minimal Residual Disease According to Breast Cancer Subtype in Patients with Breast or Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy
    Jieon Go
    Jee Hyun Ahn
    Jung Min Park
    Soon Bo Choi
    Jee Ye Kim
    Hyung Seok Park
    Seung Il Kim
    Byeong-Woo Park
    Seho Park
    [J]. Annals of Surgical Oncology, 2023, 30 : 7060 - 7068
  • [6] Distinct Prognosis of Minimal Residual Disease According to Breast Cancer Subtype in Patients with Breast or Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy
    Go, Jieon
    Ahn, Jee Hyun
    Park, Jung Min
    Choi, Soon Bo
    Kim, Jee Ye
    Park, Hyung Seok
    Kim, Seung Il
    Park, Byeong-Woo
    Park, Seho
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7060 - 7068
  • [7] Regional Nodal Irradiation in N plus Breast cancer with complete pathologic response?- Clinical practice
    Pisco, J.
    Mendonca, V.
    Figueiredo, A.
    Delgado, D.
    Mareco, V.
    Neves, M. E.
    Simas, M.
    Carmo da Silva, M.
    Miguel Silva, P.
    de Pina, M. F.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1038 - S1040
  • [8] Nodal pathologic complete response rates in luminal breast cancer vary by genomic risk and age
    Boughey, Judy
    Hoskin, Tanya
    Day, Courtney
    Goetz, Matthew
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 27 - 28
  • [9] The evolving role of pathologic complete response in breast cancer
    Hariharan, Nisha
    Rao, T. Subramanyeshwar
    [J]. SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (04) : 210 - +
  • [10] Stromal grading predicts pathologic complete response and prognosis in triple-negative breast cancer
    Sean M. Hacking
    Yihong Wang
    [J]. Virchows Archiv, 2023, 483 : 765 - 774
12345